-
-
-
-
-
-
-
Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook
-
-
-
-
-
-
-
Cytek Biosciences Announces $50 Million Stock Repurchase Program
-
-
-
-
-
-
-
Cytek Biosciences Reports Second Quarter 2023 Financial Results
-
-
-
-
-
-
-
Cytek® Biosciences Introduces New 20-Color AML Panel
-
-
-
-
-
-
-
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
-
-
-
-
-
-
-
Cytek Biosciences Reports Second Quarter 2022 Financial Results
-
-
-
-
-
-
-
Cytek Biosciences Acquires Tonbo Biosciences’ Cell Analysis Business
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

